Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell

被引:70
作者
Held, Matthew A. [3 ]
Curley, David P. [3 ]
Dankort, David [4 ]
McMahon, Martin [5 ,6 ]
Muthusamy, Viswanathan [1 ,2 ]
Bosenberg, Marcus W. [1 ,2 ,3 ]
机构
[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[3] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA
[4] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada
[5] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[6] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA
关键词
CANCER STEM-CELLS; INITIATING CELLS; IDENTIFICATION; PTEN; MELANOCYTES; RESISTANCE; MODEL;
D O I
10.1158/0008-5472.CAN-09-2153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Questions persist about the nature and number of cells with tumor-propagating capability in different types of cancer, including melanoma. In part, this is because identification and characterization of purified tumorigenic subsets of cancer cells has not been achieved to date. Here, we report tumor formation after injection of single purified melanoma cells derived from three novel mouse models. Tumor formation occurred after every injection of individual CD34(+)p75(-) melanoma cells, with intermediate rates using CD34(-)p75(-) cells, and rarely with CD34(-)p75(+) cells. These findings suggest that tumorigenic melanoma cells may be more common than previously thought and establish that multiple distinct populations of melanoma-propagating cells (MPC) can exist within a single tumor. Interestingly, individual CD34(-)p75(-) MPCs could regenerate cellular heterogeneity after tumor formation in mice or multiple passages in vitro, whereas CD34(+)p75(-) MPCs underwent self-renewal only, showing that reestablishment of tumor heterogeneity is not always a characteristic of individual cells capable of forming tumors. Functionally, single purified MPCs were more resistant to chemotherapy than non-MPCs. We anticipate that purification of these MPCs may allow a more comprehensive evaluation of the molecular features that define tumor-forming capability and chemotherapeutic resistance in melanoma. Cancer Res; 70(1); 388-97. (C) 2010 AACR.
引用
收藏
页码:388 / 397
页数:10
相关论文
共 35 条
[1]   Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[3]   Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma [J].
Bolander, Asa ;
Agnarsdottir, Margret ;
Wagenius, Gunnar ;
Stromberg, Sara ;
Ponten, Fredrik ;
Ekman, Simon ;
Brattstrom, Daniel ;
Larsson, Anders ;
Einarsson, Roland ;
Ullenhag, Gustav ;
Hesselius, Patrik ;
Bergqvist, Michael .
MELANOMA RESEARCH, 2008, 18 (06) :412-419
[4]   Characterization of melanocyte-specific inducible Cre recombinase transgenic mice [J].
Bosenberg, M ;
Muthusamy, V ;
Curley, DR ;
Wang, ZX ;
Hobbs, C ;
Nelson, B ;
Nogueira, C ;
Horner, JW ;
DePinho, R ;
Chin, L .
GENESIS, 2006, 44 (05) :262-267
[5]   Malignant melanoma: genetics and therapeutics in the genomic era [J].
Chin, Lynda ;
Garraway, Levi A. ;
Fisher, David E. .
GENES & DEVELOPMENT, 2006, 20 (16) :2149-2182
[6]  
Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
[7]   A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors [J].
Dankort, David ;
Filenova, Elena ;
Collado, Manuel ;
Serrano, Manuel ;
Jones, Kirk ;
McMahon, Martin .
GENES & DEVELOPMENT, 2007, 21 (04) :379-384
[8]   BrafV600E cooperates with Pten loss to induce metastatic melanoma [J].
Dankort, David ;
Curley, David P. ;
Cartlidge, Robert A. ;
Nelson, Betsy ;
Karnezis, Anthony N. ;
Damsky, William E., Jr. ;
You, Mingjian J. ;
DePinho, Ronald A. ;
McMahon, Martin ;
Bosenberg, Marcus .
NATURE GENETICS, 2009, 41 (05) :544-552
[9]   β-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development [J].
Delmas, Veronique ;
Beermann, Friedrich ;
Martinozzi, Silvia ;
Carreira, Suzanne ;
Ackermann, Julien ;
Kumasaka, Mayuko ;
Denat, Laurence ;
Goodall, Jane ;
Luciani, Flavie ;
Viros, Amaya ;
Demirkan, Nese ;
Bastian, Boris C. ;
Goding, Colin R. ;
Larue, Lionel .
GENES & DEVELOPMENT, 2007, 21 (22) :2923-2935
[10]   Looking ahead in cancer stem cell research [J].
Dick, John E. .
NATURE BIOTECHNOLOGY, 2009, 27 (01) :44-46